Preventive effects of transdermal 17β-estradiol on osteoporotic changes after surgical menopause: A two-year placebo-controlled trial
- 1 January 1993
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 168 (1) , 114-121
- https://doi.org/10.1016/s0002-9378(12)90897-2
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The effect of age and menopause on bone mineral density of the proximal femurJournal of Bone and Mineral Research, 1989
- Hip Fracture and the Use of Estrogens in Postmenopausal WomenNew England Journal of Medicine, 1987
- Dose dependent response of symptoms, pituitary, and bone to transdermal oestrogen in postmenopausal women.BMJ, 1986
- Involutional OsteoporosisNew England Journal of Medicine, 1986
- Biologic Effects of Transdermal EstradiolNew England Journal of Medicine, 1986
- Rates of bone loss in the appendicular and axial skeletons of women. Evidence of substantial vertebral bone loss before menopause.Journal of Clinical Investigation, 1986
- Quantitative computed tomography for prediction of vertebral fracture riskBone, 1985
- BONE MASS IN POSTMENOPAUSAL WOMEN AFTER WITHDRAWAL OF OESTROGEN/GESTAGEN REPLACEMENT THERAPYThe Lancet, 1981
- Decreased Risk of Fractures of the Hip and Lower Forearm with Postmenopausal Use of EstrogenNew England Journal of Medicine, 1980
- POST-MENOPAUSAL $OElig;STROGENS PROTECT AGAINST FRACTURES OF HIP AND DISTAL RADIUS A Case-control StudyThe Lancet, 1979